Acute Migraine Treatment Market Predicted to Reach USD 7 billion by 2031, Recording Over a 15% CAGR Says, Transparency Market Research
18. August 2023 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global market for acute migraine treatment was estimated to be worth a market valuation...
Nutra Pharma Begins Affiliate Sales & Marketing Program for the Distribution of Nyloxin(TM)
02. Mai 2012 09:18 ET
|
Nutra Pharma Corporation
CORAL SPRINGS, Fla., May 2, 2012 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTCBB:NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency...
Can Common Pain Relievers Do More Harm Than Good?
20. September 2011 11:26 ET
|
BioResource, Inc.
SAN FRANCISCO, CA--(Marketwire - Sep 20, 2011) - When it comes to relieving the common headache or body aches, it seems as if the cure may be worse for you than the pain it's supposed to relieve.
...